Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection

NCT04357730 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Severe Acute Respiratory Syndrome
Respiratory Failure
Acute Respiratory Distress Syndrome

Interventions

DRUG: Alteplase 50 MG [Activase]
DRUG: Alteplase 50 MG [Activase]

Sponsor

Denver Health and Hospital Authority

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]